Search Results

Patent adds to Envoy Medical’s expanding intellectual property portfolio, reinforcing the Company’s leadership in next generation cochlear implant innovation

Sensible Medical , creator of the ReDS pulmonary congestion monitor, announces the publication of The ReDS-SAFE HF Trial; an international, multicenter, investigator initiated, randomized controlled trial, demonstrating a significant improvement in heart failure patients’ clinical outcomes by utilizing Remote Dielectric Sensing (ReDS)

The current state of political affairs in the U.S. does not bode well for the direction of that turn. The country is at real risk of losing its long-held lead in biotech innovation.

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.